Effets cardio-vasculaires des inhibiteurs de la cholinestérase dans la maladie d’Alzheimer
Authors:
- 31 October 2007
- journal article
- abstracts
- Published by Elsevier in Revue Neurologique
- Vol. 163 (10) , 968-974
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Dementia in Subjects Aged 75 Years or Over within the PAQUID Cohort: Prevalence and Burden by SeverityDementia and Geriatric Cognitive Disorders, 2006
- Mild cognitive impairmentThe Lancet, 2006
- Cholinesterase inhibitors for Alzheimer's diseaseCochrane Database of Systematic Reviews, 2006
- Cardiovascular Effects and Risk of Syncope Related to Donepezil in Patients with Alzheimer???s DiseaseCNS Drugs, 2006
- Causes of Syncope in Patients with Alzheimer???s Disease Treated with DonepezilDrugs & Aging, 2005
- Clinically Significant Drug Interactions with Cholinesterase InhibitorsCNS Drugs, 2003
- Cholinergic Adverse Effects of Cholinesterase Inhibitors in Alzheimer??s DiseaseDrugs & Aging, 2001
- Adverse effects associated with the use of donepezil in general practice in EnglandJournal of Psychopharmacology, 2000
- Donepezil Therapy in Clinical PracticeArchives of Neurology, 2000
- “Mini-mental state”Journal of Psychiatric Research, 1975